International Money Express, Inc. (IMXI) Cash Flow Statement

The extreme OCF/NI dispersion suggests reported net income bears little relationship to cash generation in any single quarter, consistent with a settlement-heavy remittance model where timing of customer funds dominates the cash flow statement. Cumulative operating cash flow of $165.2M over ten quarters against $96.2M in net income implies non-cash charges and settlement timing, rather than durable earnings accretion, explain the gap. Investors should not treat any single quarter's OCF as representative of the business's true cash generation capacity.

The pattern shows a discernible seasonal cadence: Q1 and Q2 quarters tend to generate positive working capital inflows while Q3 and Q4 consistently drain cash, suggesting settlement cycles are tied to remittance seasonality rather than management's balance sheet discipline. The Q2 2026 inflow of $96.5M against revenue of only $131.2M implies the working capital swing alone exceeds 73% of quarterly revenue, which is operationally meaningful but potentially non-recurring. Any normalization of settlement timing could erase the apparent cash generation strength investors observed in the most recent quarter.

Excluding working capital swings, underlying free cash flow appears to hover in the $30-40M range per positive quarter, which against reported net income in the $5-15M range suggests the business generates meaningful operating cash beyond reported profitability. However, the pattern of alternating large positive and negative FCF quarters implies that external observers cannot predict liquidity direction from earnings trajectories alone. The sustained negative FCF run from 2025Q3 through 2026Q1 — totaling approximately $98M — followed by a $107M rebound illustrates why cash flow trajectory analysis for IMXI requires settlement-adjusted rather than reported metrics.

With D&A running at $4.4-4.8M per quarter, normal capex of $4-7M appears roughly maintenance-level, but the 2025Q4 spike may represent growth capital whose returns are not yet visible in subsequent revenue figures. Given that revenue has continued contracting through 2026Q2, if the elevated capex represented growth-oriented investment, its payback appears delayed, warranting further investigation into whether these assets are generating incremental returns. The return to $5.5M in 2026Q1-2026Q2 suggests the spend was episodic rather than indicative of sustained capacity expansion.

The absence of dividends across all ten reported quarters further confirms a capital deployment strategy that appears to favor liquidity preservation or balance sheet strengthening over direct shareholder distributions. The buyback cessation coincides with the negative-FCF period from 2025Q3 through 2026Q1, suggesting the pause may reflect prudent liquidity management rather than a permanent shift in capital allocation philosophy. Investors should monitor whether repurchases resume once settlement-driven cash flows stabilize, as a resumed buyback could signal management confidence in the durability of underlying cash generation.